NeVa™ Drop Zones continue to impress at WLNC

VESALIO's™ NeVa attracted interest from the participants from all over the world at the 19th World Live Neurovascular Conference which took place in Barcelona from 1st to 3rd May. Physicians visited the VESALIO booth and discovered the distinct design engineered to improve first pass success with all clot types.


During the stroke session on May 3rd, Professor Dr Serdar Geyik (Medical Park Hospital, Istanbul/ TURKEY) presented his outstanding experience with the device and shared his tips on how to maximize its clot interaction capabilities. Professor Geyik’s series of 41 MCA occlusions impressed the attendees with the 78% first pass rate (TICI 2B+) and 100% final recanalization rate (TICI 2B+). Professor Cekirge (WLNC Organizing Committee) commented that the design of NeVa and the presented results were very interesting and Professor Geyik shared that he is aware of VESALIO preparing to launch new additions to its stroke portfolio, taking the drop zone concept to the next level.


Vesalio is proud to have sponsored the WLNC meeting and thrilled with the level of excitement generated at this top-notch live course.





#dothedropzone #neva #leavenoclotbehind #ischemicstroke #firstpasssuccess

Vesalio_CircleLogo_White.png

About

Technology

Careers

  • White LinkedIn Icon
  • White Facebook Icon
  • White Twitter Icon

NeVa T, M1, M1-S and VS are CE-Marked

Caution - Investigational Device Limited by Federal Law

to Investigational Use.

150x132_graphic_logo_web.gif